Parexel International is categorized under Research and Development Laboratories in Glendale, CA .
Parexel International was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 5417112 by the NAICS.
If you are seeking more information, feel free to contact Ryan Bethencourt, Other at the company’s branch by writing to 1560 East Chevy Chase Drive # 140, Glendale, California CA 91206 or by phoning (818) 254-1600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Parexel International |
Contact Person: | Ryan Bethencourt, Other |
Address: | 1560 East Chevy Chase Drive # 140, Glendale, California 91206 |
Phone Number: | (818) 254-1600 |
Website Address: | cctrials.com |
Annual Revenue (USD): | Unknown |
Location Type: | Branch |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Research and Development Laboratories |
SIC Code: | 8731 |
NAICS Code: | 5417112 |
Share This Business: |
Parexel International was started in 0 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 5417112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Ryan Bethencourt, Other for inquiries that concern Parexel International by calling the company number (818) 254-1600, as your correspondence is most welcome. Additionally, the physical location of the branch of Parexel International can be found at the coordinates 34.152732,-118.230673 as well as the street address 1560 East Chevy Chase Drive # 140 in Glendale, California 91206.
For its online presence, you may visit Parexel International’s website at cctrials.com and engage with its social media outlets through on Twitter and on Facebook.